The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Equity of access: NHS molecular diagnostics

Name: Equity of access: NHS molecular diagnostics
Uploaded: 2020-01-30T00:00:00Z
Duration: 2 min 29 s
Description: Angela George, MB, ChB, FRACP, MD, the Royal Marsden NHS Foundation Trust, London, UK, discusses where we are in terms of NHS molecular diagnostics, what the future is likely to look like and what this means for patients and clinicians at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Angela George • 30 Jan 2020

BTOG 2020

General Lung Cancer

Angela George, MB, ChB, FRACP, MD, the Royal Marsden NHS Foundation Trust, London, UK, discusses where we are in terms of NHS molecular diagnostics, what the future is likely to look like and what this means for patients and clinicians at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.